Both in Pharmaceuticals
Minerva Neurosciences vs ADC Therapeutics SA
Over the past year NERV returned +59.1% and ADCT returned −69.5%; their daily moves had a correlation of -0.03.
NERV +59.1% ADCT −69.5%Growth of $1, one year, split-adjusted
| Metric | NERV | ADCT |
|---|---|---|
| Price | $3.35 | $1.22 |
| Market cap | $160.0M | $155.8M |
| Today | 0.00% | −0.81% |
| 1 month | −26.5% | +4.3% |
| 6 months | −44.4% | −67.5% |
| Year to date | −16.7% | −65.4% |
| 1 year | +59.5% | −69.7% |
| Revenue growth (YoY) | — | +2.2% |
| Gross margin | — | 87.8% |
| Net margin | — | −86.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.0× |
| Net cash | $75.3M | $102.5M |
| Dividend yield | — | — |
| Volatility (60d) | 77.8% | 75.3% |
| Short % of float | 6.0% | 5.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).